These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 26258765)

  • 1. New Therapies in the Treatment of High Cholesterol: An Argument to Return to Goal-Based Lipid Guidelines.
    Shrank WH; Barlow JF; Brennan TA
    JAMA; 2015 Oct; 314(14):1443-4. PubMed ID: 26258765
    [No Abstract]   [Full Text] [Related]  

  • 2. How far down to push the LDL cholesterol? PCSK9 where statins fail.
    Simko V; Ginter E
    Bratisl Lek Listy; 2016; 117(4):193-4. PubMed ID: 27075380
    [No Abstract]   [Full Text] [Related]  

  • 3. Cholesterol limits lose their lustre.
    Ledford H
    Nature; 2013 Feb; 494(7438):410-1. PubMed ID: 23446392
    [No Abstract]   [Full Text] [Related]  

  • 4. New Strategies to Treat High Cholesterol.
    Blum CB; Stone NJ
    JAMA; 2016 Mar; 315(11):1169. PubMed ID: 26978218
    [No Abstract]   [Full Text] [Related]  

  • 5. New Strategies to Treat High Cholesterol--Reply.
    Shrank WH; Barlow J
    JAMA; 2016 Mar; 315(11):1169-70. PubMed ID: 26978219
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cholesterol associated to low density lipoproteins (LDL) and vascular risk reduction. Proprotein convertase subtilisin/kexin type 9 (PCSK9): A new therapeutic target].
    Guijarro C; Ruilope LM
    Med Clin (Barc); 2015 Jul; 145(2):67-9. PubMed ID: 26004275
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effective LDL cholesterol reduction for high risk patients].
    Einecke D
    MMW Fortschr Med; 2016 Apr; 158(8):84. PubMed ID: 27116175
    [No Abstract]   [Full Text] [Related]  

  • 8. PCSK9 inhibition - a novel mechanism to treat lipid disorders?
    Banach M; Rizzo M; Obradovic M; Montalto G; Rysz J; Mikhailidis DP; Isenovic ER
    Curr Pharm Des; 2013; 19(21):3869-77. PubMed ID: 23286435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihyperlipidemic therapies targeting PCSK9.
    Weinreich M; Frishman WH
    Cardiol Rev; 2014; 22(3):140-6. PubMed ID: 24407047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antibodies in addition to statin therapy lowers LDL cholesterol].
    Bossenmayer S
    Dtsch Med Wochenschr; 2012 Sep; 137(36):1728. PubMed ID: 23281534
    [No Abstract]   [Full Text] [Related]  

  • 11. Dyslipidaemia in 2015: Advances in treatment of dyslipidaemia.
    Grundy SM
    Nat Rev Cardiol; 2016 Feb; 13(2):74-5. PubMed ID: 26763537
    [No Abstract]   [Full Text] [Related]  

  • 12. New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes.
    Sahebkar A; Watts GF
    Clin Ther; 2013 Aug; 35(8):1082-98. PubMed ID: 23932550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Winner by points?--LDL cholesterol as a target for therapeutic intervention.
    Tietge UJ
    Curr Opin Lipidol; 2013 Jun; 24(3):277-8. PubMed ID: 23652473
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug combination therapies for patients with hyperlipidemia and its significance].
    Onuma T; Kawamori R
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():566-71. PubMed ID: 11347133
    [No Abstract]   [Full Text] [Related]  

  • 15. Predicting the Overuse of PCSK-9 Inhibitors.
    Rodriguez-Gutierrez R; Shah ND; Montori VM
    JAMA; 2015 Nov; 314(18):1909-10. PubMed ID: 26547456
    [No Abstract]   [Full Text] [Related]  

  • 16. Highlights of the 83rd European Atherosclerosis Society (EAS) annual Congress, Glasgow 22-25 March, 2015.
    Stock J
    Atherosclerosis; 2015 Sep; 242(1):45-7. PubMed ID: 26177273
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of PCSK9: is this the way forward for managing residual risk?
    Chowdhury SR; Rees A
    Curr Opin Lipidol; 2012 Oct; 23(5):509-10. PubMed ID: 22964999
    [No Abstract]   [Full Text] [Related]  

  • 18. [In addition to atorvastatin. Innovative antibody lowers LDL around 72%].
    Einecke D
    MMW Fortschr Med; 2012 Apr; 154(7):28. PubMed ID: 22558865
    [No Abstract]   [Full Text] [Related]  

  • 19. [PCSK9 as new target in hyperlipidemia treatment].
    Stawowy P; Kelle S; Fleck E
    Herz; 2014 Jun; 39(4):466-9. PubMed ID: 23925411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy and clinical trials.
    Sodhi N; Krasuski RA
    Curr Opin Lipidol; 2013 Jun; 24(3):281-2. PubMed ID: 23652475
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.